Sfoglia per AUTORE
ALBANO F
Collezione AOU Novara

  

Items : 8

Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study. in Hematological oncology / Hematol Oncol. 2024 Jan;42(1):e3216. doi: 10.1002/hon.3216. Epub 2023 Sep 29.

2024
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Molica S; Iannella E; Malgieri S; Gozzetti A; Gualberti G; Caira M; Finsinger P; Reda G; Coscia M; Vallisa D; Pane F; Cuneo A; Albano F; Zamprogna G; Trentin L; Mauro FR; Albi E; Gaidano G; Laurenti L; Sportoletti P; Chiarenza A;

Effects of daratumumab on hematopoietic stem cell collection and engraftment in multiple myeloma patients eligible for autologous transplantation: results of the real-life PRIMULA study comparing bortezomib, thalidomide and dexamethasone (VTd) with VTd plus daratumumab (D-VTd) as induction therapy. in Annals of hematology / Ann Hematol. 2024 Aug 22. doi: 10.1007/s00277-024-05933-3.

2024
AOU Novara

Tarantini F; Buda G; Rizzi R; Curci P; Attolico I; Carluccio P; Ostuni A; Sgherza N; Strafella V; Del Giudice ML; Marasco V; Mele A; Margiotta-Casaluci G; Valli VB; Mele G; Germano CR; Quinto AM; Palazzo G; Febbo MA; Ciuffreda L; Reddiconto G; Di Renzo N; Cimminiello M; Albano F; Musto P;

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.

2023
AO Alessandria
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano
ASL Cuneo 1
AOU Novara

Cuneo A; Piciocchi A; Vignetti M; Fazi P; Foà R; Del Giudice I; De Propris MS; Nanni M; Molinari MC; Pietrasanta D; Mattiello V; Visentin A; Vitale C; Albano F; Neri A; De Novi LA; Tani M; Arcari A; Scarfò L; Giordano A; Gottardi D; Liberati AM; Galieni P; Patrizi VB; Deodato M; Musuraca G; Levato L; Marchetti M; Mannina D; et alii...

Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study. in Haematologica / Haematologica. 2022 Jun 1;107(6):1470-1473. doi: 10.3324/haematol.2021.280325.

2022
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AOU Novara

Cuneo A; Laurenti L; Ghia P; Foà R; Trentin L; Pompili M; Tedeschi A; Mauro FR; Del Poeta G; Scarfò L; Autore F; Tomasso A; Di Sevo D; Arena V; Deodato M; Ielo C; Frustaci AM; Piciocchi A; Rughini A; Cassin R; Albano F; Quaglia FM; Pennese E; Moia R; Gentile M; Murru R; Motta M; Coscia M; Visentin A; et alii...

Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia. in Leukemia & lymphoma / Leuk Lymphoma. 2021 Mar;62(3):669-678. doi: 10.1080/10428194.2020.1838509. Epub 2020 Nov 6.

2021
AOU Novara

Efficace F; Iurlo A; Patriarca A; Stagno F; Bee PC; Ector G; Capodanno I; Elena C; Bonifacio M; Blijlevens NMA; Caocci G; Wan C; Abruzzese E; Breccia M; Cottone F; Okumura I; Oerlemans S; Cascavilla N; Albano F; Kota V; Sztankay M; Miggiano MC; Saussele S; Di Renzo N; Sorà F; Castagnetti F; Baccarani M; Vignetti M; Rosti G; et alii...

Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network. in Frontiers in oncology / Front Oncol. 2021 Aug 26;11:739171. doi: 10.3389/fonc.2021.739171. eCollection 2021.

2021
AOU Città della Salute di Torino
AOU Novara

Ciccone G; Baccarani M; Saglio G; Di Raimondo F; Pane F; Rosti G; Musto P; Saccona F; Mulas O; Levato L; Guella A; La Barba G; Pietrantuono G; Miggiano MC; Abruzzese E; Giai V; De Candia MS; Sanpaolo G; Maggi A; Reddiconto G; DiTonno P; Binotto G; Galimberti S; Bocchia M; Sorà F; Rege-Cambrin G; Patriarca A; Fava C; Bergamaschi M; et alii...

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP. in Blood advances / Blood Adv. 2019 Dec 23;3(24):4280-4290. doi: 10.1182/bloodadvances.2019000865.

2019
AOU Città della Salute di Torino
AO Cuneo
AO Alessandria
AOU Novara

Soverini S; Vigneri P; Rosti G; Bonifacio M; Breccia M; Castagnetti F; Saglio G; Pane F; Russo D; Trabacchi E; Spadano R; Stagno F; Tiribelli M; Tomassetti S; Sancetta R; Sica S; Salvucci M; Rupoli S; Rege-Cambrin G; Rapezzi D; Pregno P; Miggiano MC; Montefusco E; Musolino C; Palmieri F; Malagola M; Melpignano A; Martino B; Marasca R; et alii...

Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia. in American journal of hematology / Am J Hematol. 2016 Jun;91(6):617-22. doi: 10.1002/ajh.24362. Epub 2016 Apr 24.

2016
AOU San Luigi di Orbassano
AOU Novara

Pane F; Martinelli G; Alimena G; Cavo M; Soverini S; Venturi C; Levato L; Musolino C; Pia Falcone A; Lunghi M; Tiribelli M; Cavazzini F; Bocchia M; D'Adda M; Luciano L; Stagno F; Albano F; Martino B; Abruzzese E; Rege-Cambrin G; Usala E; Carella AM; Gozzini A; Breccia M; Castagnetti F; Gugliotta G; Saglio G; Rosti G; Baccarani M; et alii...